Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

By simulating various scenarios, predictive models help public health officials weigh the trade-offs between different ...

During the COVID-19 pandemic, suppression of scientific debate and the marginalization of dissenting voices weakened public ...

Now is the time for policy makers, payers, health systems, and clinicians to act decisively by extending AHCaH, evaluating ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Massachusetts’ new health care reform expands the authority of the state to intervene prior to significant changes to the ...

As health scholars at the American Enterprise Institute, the Brookings Institution, and the Bipartisan Policy Center, we ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Eric Topol, Executive Vice President of Scripps Research, on his new ...

Unless Congress acts to renew them by the end of this year, enhanced premium subsidies for the Affordable Care Act’s ...

This article highlights a striking example of pointless complexity in the US health care system: the 24 (or more) separate ...

To address the demand-side of this fight, a prevention and treatment-based approach is necessary, as state officials can ...

The escalating threat of climate change is not just an environmental concern; it is increasingly becoming a workplace hazard.